Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation

Ankylosing spondylitis (AS) is a chronic inflammatory disease that causes spinal inflammation and fusion. Although the cause of AS is unknown, genetic factors (e.g., HLA-B27) and environmental factors (e.g., sex, age, and infection) increase the risk of AS. Current treatments for AS are to improve s...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Jeonghyeon, Lee, Seon-Yeong, Na, Hyun Sik, Lee, A Ram, Cho, Keun-Hyung, Choi, Jeong Won, Park, Sung-Hwan, Cho, Mi-La
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428320/
https://www.ncbi.nlm.nih.gov/pubmed/36059546
http://dx.doi.org/10.3389/fimmu.2022.922531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428320/
https://www.ncbi.nlm.nih.gov/pubmed/36059546
http://dx.doi.org/10.3389/fimmu.2022.922531

Ejemplares similares